HomeCEL • LON
add
Celadon Pharmaceuticals PLC
Previous close
GBX 97.50
Day range
GBX 89.20 - GBX 100.00
Year range
GBX 75.00 - GBX 180.00
Market cap
61.87M GBP
Avg Volume
52.93K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
(GBP) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 33.50K | 425.82% |
Operating expense | 1.32M | -29.03% |
Net income | -1.42M | 24.47% |
Net profit margin | -4.24K | 85.64% |
Earnings per share | — | — |
EBITDA | -1.17M | 34.21% |
Effective tax rate | 8.06% | — |
Balance Sheet
Total assets
Total liabilities
(GBP) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.26M | -75.12% |
Total assets | 9.22M | -30.41% |
Total liabilities | 6.04M | -2.80% |
Total equity | 3.18M | — |
Shares outstanding | 62.50M | — |
Price to book | 19.50 | — |
Return on assets | -35.35% | — |
Return on capital | -41.28% | — |
Cash Flow
Net change in cash
(GBP) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.42M | 24.47% |
Cash from operations | -1.49M | 3.42% |
Cash from investing | -66.50K | 85.76% |
Cash from financing | 1.38M | 90,063.40% |
Net change in cash | -176.00K | 91.23% |
Free cash flow | -904.19K | 35.17% |
About
Founded
2018
Website
Employees
24